Mobile navigation

  • Tests

    Tests for Providers

    Clinical Tests

    Afirma
    Genomic Sequencing Classifier
    Decipher
    Bladder Genomic Classifier
    Decipher
    Prostate Genomic Classifier

    Prosigna
    Breast Risk of
    Recurrence Test

    Discover

    Provider Resource Center Scientific Publications Veracyte Diagnostics Platform Clinical Studies

    Connect With Us

    Ordering Portal Contact Us

    Tests for Patients

    Cancer Tests

    Afirma
    Thyroid Nodule Test
    Decipher
    Bladder Cancer Test
    Decipher
    Prostate Cancer Test

    Prosigna
    Breast Cancer Test

    Learn

    Patient Resource Center Patient Video Stories Frequently Asked Questions

    Need Help?

    Payment Portal Contact Us
  • Resources

    Resources for Providers

    Resource Centers

    Afirma Thyroid Resources Decipher Bladder Resources Decipher Prostate Resources Prosigna Breast Resources View All →

    Explore

    Scientific Publications Frequently Asked Questions Video Gallery Document Library Cancer Diagnostic Labs

    Connect With Us

    Ordering Portal Contact Us

    Resources for Patients

    Resource Centers

    Afirma Thyroid Resources Decipher Bladder Resources Decipher Prostate Resources Prosigna Breast Resources View All →

    Explore

    Patient Video Stories Frequently Asked Questions

    Connect With Us

    Payment Portal Contact Us
  • Innovation

    Technology

    Veracyte Diagnostics Platform Clinical Studies Technology & Pipeline

    TrueMRD Platform Cancer Diagnostic Labs

    Research Use Only

    Afirma GRID Decipher GRID
  • Company

    About Us

    About Veracyte Leadership Careers Working at Veracyte

    News & Events

    Events & Webinars Press Releases In the News Blog

    Connect

    Contact Us
  • Investors

    Welcome

    Overview Press Releases Events & Presentations

    Financials

    SEC Filings Quarterly Results Annual Reports Stock Information Analyst Coverage

    Governance

    Governance Overview Board of Directors Committee Composition Leadership ESG Information

    Investor Resources

    Investor FAQs Information Request Email Alerts
Contact UsPortals

Search

  • Patient Payment Portal
  • Provider Portal
Logo of Veracyte company. A stylized checkmark with a purple tip and blue body on the left, followed by black text on the right. The logo is set against a plain white background.
  • Tests

    Clinical Tests

    Afirma
    Genomic Sequencing Classifier
    Decipher
    Bladder Genomic Classifier
    Decipher
    Prostate Genomic Classifier

    Prosigna
    Breast Risk of
    Recurrence Test

    Discover

    Provider Resource Center Scientific Publications Veracyte Diagnostics Platform Clinical Studies

    Connect With Us

    Ordering Portal Contact Us

    Cancer Tests

    Afirma
    Thyroid Nodule Test
    Decipher
    Bladder Cancer Test
    Decipher
    Prostate Cancer Test

    Prosigna
    Breast Cancer Test

    Learn

    Patient Resource Center Patient Video Stories Frequently Asked Questions

    Need Help?

    Payment Portal Contact Us
  • Resources

    Resource Centers

    Afirma Thyroid Resources Decipher Bladder Resources Decipher Prostate Resources Prosigna Breast Resources View All →

    Explore

    Scientific Publications Frequently Asked Questions Video Gallery Document Library Cancer Diagnostic Labs

    Connect With Us

    Ordering Portal Contact Us

    Resource Centers

    Afirma Thyroid Resources Decipher Bladder Resources Decipher Prostate Resources Prosigna Breast Resources View All →

    Explore

    Patient Video Stories Frequently Asked Questions

    Connect With Us

    Payment Portal Contact Us
  • Innovation

    Technology

    Veracyte Diagnostics Platform Clinical Studies Technology & Pipeline

    TrueMRD Platform Cancer Diagnostic Labs

    Research Use Only

    Afirma GRID Decipher GRID
  • Company

    About Us

    About Veracyte Leadership Careers Working at Veracyte

    News & Events

    Events & Webinars Press Releases In the News Blog

    Connect

    Contact Us
  • Investors

    Welcome

    Overview Press Releases Events & Presentations

    Financials

    SEC Filings Quarterly Results Annual Reports Stock Information Analyst Coverage

    Governance

    Governance Overview Board of Directors Committee Composition Leadership ESG Information

    Investor Resources

    Investor FAQs Information Request Email Alerts

Accessibility Statement

At Veracyte we are committed to ensuring digital accessibility for our website visitors. We strive to meet the standards set forth by the World Wide Web Consortium’s Web Content Accessibility Guidelines (WCAG) 2.2 at the A and AA levels. Our goal is to make our website user-friendly and accessible to everyone, regardless of ability.

Our commitment to accessibility

We are dedicated to providing an accessible website experience for all users, including those with disabilities. To achieve this goal, we have implemented the following measures:

  1. Regular Accessibility audits: We conduct regular audits of our website to identify accessibility barriers and make necessary improvements.
  2. Accessibility features: Our website incorporates features such as alternative text for images, keyboard navigation, and semantic HTML to enhance accessibility.
  3. User feedback: We welcome feedback from users regarding accessibility issues. If you encounter any barriers while using our website, please contact us at [email protected] so that we can address them promptly.
  4. Training: Our team members are trained on accessibility best practices to ensure that they understand the importance of accessibility and how to implement it effectively.

Accessibility standards

Our efforts to ensure accessibility are guided by the Web Content Accessibility Guidelines (WCAG) 2.2 at the A and AA levels. These guidelines outline best practices for making web content more accessible to people with disabilities.

Feedback

If you have any questions or concerns regarding the accessibility of our website, or if you encounter any accessibility barriers, please contact [email protected]. We are committed to providing a positive experience for all users and will do our best to address your concerns promptly.

Continuous improvement

Accessibility is an ongoing effort, and we are continuously working to improve the accessibility of our website. We are committed to staying up-to-date with the latest accessibility standards and best practices to ensure that all users can access and interact with our website effectively.

Date of last update:

This accessibility statement was last updated on April 1, 2026. Any changes or updates to our accessibility efforts will be reflected in this statement.

For more information about web accessibility and the WCAG guidelines, please visit the following resources:

  1. WCAG 2.2 Quick Reference
  2. W3C Web Accessibility Initiative (WAI)
  3. WebAIM – Web Accessibility In Mind
Contact UsPortals
Logo of Veracyte company. A stylized checkmark with a purple tip and blue body on the left, followed by black text on the right. The logo is set against a plain white background.
6000 Shoreline Court, Suite 300
San Francisco, CA 94080
+1-650-243-6335
  • Contact Us

Connect:

  • linkedin logo
  • Logo of X company
  • Logo of youtube

  • Afirma
    Genomic Sequencing Classifier
  • Decipher
    Bladder Genomic Classifier
  • Decipher
    Prostate Genomic Classifier
  • Prosigna
    Breast Risk of Recurrence Test

  • Veracyte Diagnostics
    Platform
  • Clinical Studies
  • Technology & Pipeline
  • Scientific Publications
  • Resource Center
  • Document Library
  • Portals

  • In the News
  • Press Releases
  • Events & Webinars

  • About Veracyte
  • Leadership
  • Careers
  • Investors
  • Blog
  • Corporate Recognition
© 2026 Veracyte, Inc. All rights reserved.
  • Instructions for Use
  • Safety Data Sheets
  • Privacy Notice
  • Accessibility
  • Terms of Use
  • Terms of Sale
  • No Surprises Act
  • Ethics & Compliance
  • Licenses & Certifications
  • Trademarks
  • Site Map
Global

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.